We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Cohen & Steers
CNS
$4.3B
| $16.1M | 0.01% |
257,093
+92,483
| +56% | +$6.61M |
|
|
KNBE
1152
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $16.1M | 0.01% |
773,237
+356,512
| +86% | +$6.57M |
|
|
SGFY
1153
DELISTED
Signify Health, Inc.
SGFY
| $16.1M | 0.01% |
551,666
+347,492
| +170% | +$8M |
|
1154
Trex
TREX
$5.01B
| $16.1M | 0.01% |
365,949
-158,168
| -30% | -$8.46M |
|
1155
Rush Enterprises Class A
RUSHA
$6.22B
| $16.1M | 0.01% |
549,573
-2,960
| -0.5% | -$95.2K |
|
1156
Chemed
CHE
$7.22B
| $16.1M | 0.01% |
36,802
-1,593
| -4% | -$766K |
|
|
DEA
1157
Easterly Government Properties
DEA
$1.18B
| $16.1M | 0.01% |
407,187
+44,451
| +12% | +$2.06M |
|
|
LMACU
1158
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
| $16M | 0.01% |
1,611,717
| – | – |
|
1159
Louisiana-Pacific
LPX
$5.49B
| $16M | 0.01% |
312,827
-140,985
| -31% | -$8.01M |
|
1160
Range Resources
RRC
$8.95B
| $16M | 0.01% |
631,768
-73,249
| -10% | -$2.22M |
|
1161
Hyatt Hotels
H
$16.7B
| $16M | 0.01% |
197,089
-21,017
| -10% | -$1.79M |
|
1162
Viasat
VSAT
$11.1B
| $15.9M | 0.01% |
527,082
-10,456
| -2% | -$350K |
|
1163
Omega Healthcare
OHI
$14.7B
| $15.9M | 0.01% |
539,927
-13,181
| -2% | -$413K |
|
1164
Pebblebrook Hotel Trust
PEB
$2.05B
| $15.9M | 0.01% |
1,096,803
+199,308
| +22% | +$3.59M |
|
1165
Bloomin' Brands
BLMN
$938M
| $15.9M | 0.01% |
867,481
-233,320
| -21% | -$4.64M |
|
|
SF
1166
Stifel
SF
$12.6B
| $15.8M | 0.01% |
457,163
-12,645
| -3% | -$498K |
|
|
VRNT
1167
DELISTED
Verint Systems
VRNT
| $15.8M | 0.01% |
470,091
+39,862
| +9% | +$1.74M |
|
1168
STAAR Surgical
STAA
$1.21B
| $15.8M | 0.01% |
223,565
-31,439
| -12% | -$2.69M |
|
1169
Universal Display
OLED
$4.19B
| $15.8M | 0.01% |
167,106
-4,411
| -3% | -$488K |
|
1170
Arrowhead Research
ARWR
$12.4B
| $15.7M | 0.01% |
476,375
-223,901
| -32% | -$9.04M |
|
1171
Progress Software
PRGS
$1.76B
| $15.7M | 0.01% |
368,107
-160,854
| -30% | -$7.43M |
|
1172
Axos Financial
AX
$5.68B
| $15.6M | 0.01% |
456,720
-6,226
| -1% | -$252K |
|
|
COWN
1173
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $15.6M | 0.01% |
404,319
-20,560
| -5% | -$748K |
|
1174
Choice Hotels
CHH
$4.8B
| $15.6M | 0.01% |
142,613
+3,477
| +2% | +$399K |
|
|
UCTT
1175
Ultra Clean Holdings
UCTT
$3.95B
| $15.6M | 0.01% |
605,458
-106,913
| -15% | -$3.27M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.